community acquired methicillin resistant Staphylococcus aureus in new patients attending a government hospital in Gangtok, Sikkim.

Journal of Pharmaceutical and Biomedical Sciences 06/2012; 19(19):1-3.

ABSTRACT Prevalence of methicillin resistant Staphylococcus aureus (MRSA) is increasing in the community and has become an emerging public health problem. Community acquired MRSA (CA-MRSA) strains differ from Hospital acquired MRSA (HA-MRSA) by causing aggressive infections like furunculosis and necrotizing pneumonia in otherwise young, healthy individuals Aim - This study was carried out to determine the prevalence of CA-MRSA in patients attending hospital from April 2010 till March 2011. Materials and Methods - 2,282 clinical samples from outpatient and hospitalized patients were screened for MRSA. CA-MRSA were identified based on the CDC definition for community acquired infection. Antibiotic resistance pattern was studied by using the Kirby baeur disk diffusion method. Risk factors for hospital associated infections were recorded Results - Of the 184 strains of S. aureus isolated, 29.3% were MRSA and 48.14% was CA-MRSA. Conclusion Methicillin resistance is an increasing menace and routine screening of all isolates is necessary.

Download full-text


Available from: Shrijana Gurung, Sep 27, 2015
38 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial pathogen responsible for a variety of infections in both children and adults. Treatment of infections caused by this organism is problematic due to its resistance to many drugs. Recent reports of community-associated MRSA (CA-MRSA) infections in patients with no known risk factors have serious public health implications. Therapeutic options for these infections are untested; therefore, the potential exists for high morbidity and mortality. Recently, clinical definitions have been established, and new molecular approaches have allowed investigators to distinguish CA-MRSA more easily from traditional nosocomial-derived MRSA strains. Identifying potential risk factors for CA-MRSA acquisition and fully characterizing the epidemiologic, clinical, and molecular properties of these strains are necessary to provide effective therapeutic guidelines.
    Pharmacotherapy 02/2005; 25(1):74-85. DOI:10.1592/phco. · 2.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Methicillin-resistant Staphylococcus aureus (MRSA), one of the most common causes of infections, has been traditionally recognized as a nosocomial pathogen. However, in recent years, its epidemiology has radically changed, being now observed even more frequently in the community, and accounting for > 50% of staphylococcal infections in the US outpatient setting. Community-acquired (CA)-MRSA strains typically cause infections among otherwise healthy individuals, with risk factors differing from those of nosocomial MRSA. The clinical manifestations may range from a furuncle to life-threatening infections, such as necrotizing fasciitis and pneumonia. The antibiotic treatment of these infections may also differ because CA-MRSA strains often retain susceptibility to antimicrobials other than glycopeptides and newer agents. Moreover, the production of toxins, such as the Panton-Valentine leukocidin (PVL), should influence the antibiotic choice because in these cases the use of a combination therapy with antimicrobial agents able to decrease toxin production is suggested. There are still many unanswered key questions regarding the epidemiology, prevention, and treatment of CA-MRSA infections. This article reviews current knowledge of CA-MRSA.
    Postgraduate Medicine 11/2010; 122(6):16-23. DOI:10.3810/pgm.2010.11.2218 · 1.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Methicillin-resistant Staphylococcus aureus (MRSA) is an important nosocomial pathogen. It can also cause community-acquired infections. Indian reports about MRSA in community-acquired infections are rare. To evaluate the rate of MRSA in community-acquired pyoderma and the nasal colonisation with S. aureus in such patients. Two hundred and fifty patients with community-acquired pyoderma, who attended outreach camps around Mangalore, south India between January 2000 and July 2001, were studied. Swabs collected from the skin lesions and anterior nares were inoculated onto blood agar and MacConkey's agar. Antimicrobial sensitivity testing was performed using Kirby-Bauer disk diffusion, agar dilution, and agar screen. Of 250 pyoderma cases, S. aureus was isolated from 202 (80.8%) patients. Twenty-two (10.9%) S. aureus isolates were methicillin resistant, 179 (88.6%) were resistant to penicillin, and 114 (56.4%) were resistant to erythromycin. S. aureus colonization in the anterior nares was observed in 136 (54.4%) cases, 11.8% of which were MRSA. Antibiograms of clinical isolates of S. aureus matched with nasal isolates in 99 (49%) cases. The emergence of MRSA in the community is a warning. A high nasal carriage rate may contribute to recurrent pyoderma. A correct antimicrobial policy and the avoidance of inappropriate antimicrobial usage are mandatory to reduce the spread of MRSA in the community.
    International Journal of Dermatology 07/2004; 43(6):412-4. DOI:10.1111/j.1365-4632.2004.02138.x · 1.31 Impact Factor
Show more